CompoAtlas

Morbillinum

Natural health product licensed in Canada

Licence holder
Laboratoire Schmidt-Nagel Inc.
NPN or DIN-HM
80046098
Status
Active licence
Licence date
12 November 2013
Revision date
Not provided
Form
Granules
Route of administration
Orale
Application type
Homéopathique

If this product were sold in France

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Morbillinum

Source : Exudats bucco-pharyngés provenant des humains infectés avec la rougeole

12 DNot calculated

Non-medicinal ingredients

Lactose, Saccharose

PopulationAgeQuantity per servingFrequency
EnfantsNot specified1 Tube1 day
Adultes et enfantsNot specified1 Tube1 day

Uses authorised in Canada

Remède homéopathique.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

Source

Official Health Canada record, licence 80046098

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line